1. Home
  2. DOV vs KVUE Comparison

DOV vs KVUE Comparison

Compare DOV & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dover Corporation

DOV

Dover Corporation

HOLD

Current Price

$230.42

Market Cap

31.5B

Sector

Industrials

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$18.67

Market Cap

33.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOV
KVUE
Founded
1947
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Specialty Chemicals
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.5B
33.1B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
DOV
KVUE
Price
$230.42
$18.67
Analyst Decision
Buy
Buy
Analyst Count
10
12
Target Price
$223.20
$19.58
AVG Volume (30 Days)
1.6M
62.2M
Earning Date
01-29-2026
02-17-2026
Dividend Yield
0.90%
4.44%
EPS Growth
N/A
35.31
EPS
7.94
0.75
Revenue
$8,092,571,000.00
$15,006,000,000.00
Revenue This Year
$6.78
N/A
Revenue Next Year
$4.48
$2.72
P/E Ratio
$29.06
$25.01
Revenue Growth
4.47
N/A
52 Week Low
$143.04
$14.02
52 Week High
$237.54
$25.17

Technical Indicators

Market Signals
Indicator
DOV
KVUE
Relative Strength Index (RSI) 73.80 74.77
Support Level $197.97 $17.96
Resistance Level $237.54 $18.97
Average True Range (ATR) 5.74 0.37
MACD 1.95 0.10
Stochastic Oscillator 85.06 85.29

Price Performance

Historical Comparison
DOV
KVUE

About DOV Dover Corporation

Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: